Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells

Vinh Dao(The University of Texas at San Antonio Health Science Center), Tyler J. Curiel(Tulane University), Vincent Hurez(The University of Texas at San Antonio Health Science Center), Yang Liu(Mudanjiang Medical University), Aijie Liu(The University of Texas Southwestern Medical Center), Robert S. Svatek(The University of Texas at San Antonio Health Science Center), Srilakshmi Pandeswara(The University of Texas at San Antonio Health Science Center), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center)
Cancer Research
August 28, 2016
10.1158/0008-5472.can-16-0091
Cited by 41

Related Papers

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Interventions to Slow Aging in Humans: Are We Ready?
|Aging Cell|2015|598
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
|Nature|2021|407
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
|Cancer Research|2016|399